Aclarion (ACONW) Competitors $0.04 0.00 (-0.28%) As of 12:23 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesSEC FilingsTrendsBuy This Stock ACONW vs. AONC, DHACW, FMS, LFMDP, OTRKP, PIIIW, TALKW, TOIIW, NTRA, and HIMSShould you be buying Aclarion stock or one of its competitors? The main competitors of Aclarion include American Oncology Network (AONC), Digital Health Acquisition (DHACW), Fresenius Medical Care AG & Co. KGaA (FMS), LifeMD (LFMDP), Ontrak (OTRKP), P3 Health Partners (PIIIW), Talkspace (TALKW), Oncology Institute (TOIIW), Natera (NTRA), and Hims & Hers Health (HIMS). These companies are all part of the "healthcare" industry. Aclarion vs. Its Competitors American Oncology Network Digital Health Acquisition Fresenius Medical Care AG & Co. KGaA LifeMD Ontrak P3 Health Partners Talkspace Oncology Institute Natera Hims & Hers Health American Oncology Network (NASDAQ:AONC) and Aclarion (NASDAQ:ACONW) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, profitability, risk, earnings, dividends and institutional ownership. Is AONC or ACONW more profitable? Company Net Margins Return on Equity Return on Assets American Oncology NetworkN/A N/A N/A Aclarion N/A N/A N/A Which has preferable earnings & valuation, AONC or ACONW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAmerican Oncology Network$1.34BN/AN/AN/AN/AAclarion$62.95KN/AN/AN/AN/A Does the media prefer AONC or ACONW? In the previous week, Aclarion had 1 more articles in the media than American Oncology Network. MarketBeat recorded 1 mentions for Aclarion and 0 mentions for American Oncology Network. Aclarion's average media sentiment score of 1.88 beat American Oncology Network's score of 0.00 indicating that Aclarion is being referred to more favorably in the news media. Company Overall Sentiment American Oncology Network Neutral Aclarion Very Positive SummaryAclarion beats American Oncology Network on 2 of the 3 factors compared between the two stocks. Get Aclarion News Delivered to You Automatically Sign up to receive the latest news and ratings for ACONW and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ACONW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ACONW vs. The Competition Export to ExcelMetricAclarionHealth Information Services IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$339.27M$5.74B$9.75BDividend YieldN/A5.90%3.95%4.07%P/E RatioN/A347.0330.3326.09Price / SalesN/A210.45462.11120.66Price / CashN/A47.1437.7259.08Price / BookN/A4.989.776.67Net IncomeN/A-$15.55M$3.27B$265.43M7 Day PerformanceN/A0.63%3.95%3.11%1 Month PerformanceN/A0.67%3.81%0.39%1 Year PerformanceN/A7.69%31.26%18.52% Aclarion Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ACONWAclarionN/A$0.04-0.3%N/A+16.2%$0.00$62.95K0.007Positive NewsAONCAmerican Oncology NetworkN/A$10.50-14.2%N/A+226.8%$0.00$1.34B0.001,520Gap UpDHACWDigital Health AcquisitionN/A$0.05-9.0%N/AN/A$0.00N/A0.00N/AFMSFresenius Medical Care AG & Co. KGaA2.8216 of 5 stars$24.86+2.7%$27.80+11.8%+30.1%$0.00$20.63B20.381,384LFMDPLifeMDN/A$23.65+0.8%N/A+8.2%$0.00$245.56M0.00230Positive NewsOTRKPOntrakN/A$0.02flatN/A-92.1%$0.00$10.84M0.00250High Trading VolumePIIIWP3 Health PartnersN/A$0.01+4.0%N/AN/A$0.00$1.49B0.00500High Trading VolumeTALKWTalkspaceN/A$0.07+0.3%N/A+70.9%$0.00$202.61M0.00500Positive NewsHigh Trading VolumeTOIIWOncology InstituteN/A$0.14-3.2%N/A+694.1%$0.00$403.15M0.00660Positive NewsNTRANatera3.121 of 5 stars$157.70-1.3%$193.87+22.9%+32.4%$21.93B$1.70B-82.574,434Positive NewsHIMSHims & Hers Health2.7509 of 5 stars$48.34+0.8%$39.83-17.6%+157.2%$10.73B$2.01B60.431,637Trending NewsInsider Trade Related Companies and Tools Related Companies AONC Alternatives DHACW Alternatives FMS Alternatives LFMDP Alternatives OTRKP Alternatives PIIIW Alternatives TALKW Alternatives TOIIW Alternatives NTRA Alternatives HIMS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ACONW) was last updated on 8/26/2025 by MarketBeat.com Staff From Our PartnersFed Decision Warning: How to Protect Your Wealth Before September 30th On September 17th, the Fed faces an impossible choice—and Wall Street insiders are already preparing for the...American Alternative | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredCover all your expenses with just $118,000 invested?Generate up to $5,000/month with 10X less money? That's what every financial advisor tells you. But I just ...Investors Alley | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aclarion, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aclarion With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access